A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.

We have developed a robust tool that is able to predict subsequent brain metastasis in mTNBC patients. Our model will allow selection of patients at high risk for brain metastasis who might benefit from routine bran MRI screening.